• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乙基 2-(2-芳亚基-1-烷基腙基)噻唑-4-羧酸酯的合成及计算机对接研究作为糖基化抑制剂。

Synthesis and in Silico Docking Studies of Ethyl 2-(2-Arylidene-1-alkylhydrazinyl)thiazole-4-carboxylates as Antiglycating Agents.

机构信息

Department of Chemistry, Mirpur University of Science and Technology (MUST), 10250-, Mirpur (AJK), Pakistan.

Department of Chemistry, Government Major Muhammad Afzal Khan (Shaheed), Boys Degree College Afzalpur, Mirpur (Affiliated with Mirpur University of Science and Technology (MUST), 10250-, Mirpur (AJK), Pakistan.

出版信息

Chem Biodivers. 2022 Feb;19(2):e202100581. doi: 10.1002/cbdv.202100581. Epub 2022 Jan 11.

DOI:10.1002/cbdv.202100581
PMID:34875137
Abstract

Ethyl 2-(2-arylidene-1-alkylhydrazinyl)thiazole-4-carboxylates (1a-k) were synthesized by alkylation on HN- of ethyl 2-(2-arylidenehydrazinyl)thiazole-4-carboxylates. The proposed structures (1a-k) are corroborated by spectro-analytical techniques like UV, FT-IR, H-, C-NMR and HR-MS. All synthesized compounds were screened for their antiglycation and antioxidant assays. The in vitro antiglycation results revealed promising activity of compounds 1a, 1b, 1d, 1e, 1f, 1g, 1j and 1k with IC values 0.0004±1.097-17.22±0.538 μM when compared to standard, aminoguanidine (IC =25.50±0.337 μM). Among all tested compounds 1j and 1k are the best antiglycating agents with IC values 1.848±0.646 and 0.0004±1.097 μM, respectively. The in-silico studies also agree with these results where binding energy for 1j and 1k was found to be -9.25 and -8.42 kcal/mol with calculated dissociation constants of 0.16 and 0.67 μM, respectively. The antiglycation results demonstrate the application of these compounds in reducing diabetic complications.

摘要

乙基 2-(2-芳亚基-1-烷基腙基)噻唑-4-羧酸酯(1a-k)通过乙基 2-(2-芳亚基腙基)噻唑-4-羧酸酯的 HN-烷基化合成。所提出的结构(1a-k)通过光谱分析技术如 UV、FT-IR、H-、C-NMR 和 HR-MS 得到证实。所有合成的化合物都进行了抗糖化和抗氧化检测。体外抗糖化结果显示,化合物 1a、1b、1d、1e、1f、1g、1j 和 1k 具有有前途的活性,IC 值为 0.0004±1.097-17.22±0.538 μM,与标准物氨基胍(IC=25.50±0.337 μM)相比。在所有测试的化合物中,1j 和 1k 是最好的抗糖化剂,IC 值分别为 1.848±0.646 和 0.0004±1.097 μM。基于结构的虚拟筛选研究也与这些结果一致,其中 1j 和 1k 的结合能分别为-9.25 和-8.42 kcal/mol,计算出的解离常数分别为 0.16 和 0.67 μM。抗糖化结果表明这些化合物可用于减少糖尿病并发症。

相似文献

1
Synthesis and in Silico Docking Studies of Ethyl 2-(2-Arylidene-1-alkylhydrazinyl)thiazole-4-carboxylates as Antiglycating Agents.乙基 2-(2-芳亚基-1-烷基腙基)噻唑-4-羧酸酯的合成及计算机对接研究作为糖基化抑制剂。
Chem Biodivers. 2022 Feb;19(2):e202100581. doi: 10.1002/cbdv.202100581. Epub 2022 Jan 11.
2
Synthesis, antioxidant, antimicrobial and antiviral docking studies of ethyl 2-(2-(arylidene)hydrazinyl)thiazole-4-carboxylates.乙基 2-(2-(亚芳基)腙基)噻唑-4-羧酸酯的合成、抗氧化、抗菌和抗病毒对接研究。
Z Naturforsch C J Biosci. 2021 Apr 26;76(11-12):467-480. doi: 10.1515/znc-2021-0042. Print 2021 Nov 25.
3
Synthesis of Arylidenehydrazinyl-4-methoxyphenylthiazole Derivatives: Docking Studies, Probing Type II Diabetes Complication Management Agents.芳亚甲基腙基-4-甲氧基苯基噻唑衍生物的合成:对接研究,探索 II 型糖尿病并发症管理药物。
Chem Biodivers. 2022 Nov;19(11):e202200824. doi: 10.1002/cbdv.202200824. Epub 2022 Oct 26.
4
4-Adamantyl-(2-(arylidene)hydrazinyl)thiazoles as potential antidiabetic agents: experimental and docking studies.4-金刚烷基-(2-(亚芳基)肼基)噻唑作为潜在的抗糖尿病药物:实验和对接研究
Future Med Chem. 2023 Apr;15(7):599-613. doi: 10.4155/fmc-2023-0010. Epub 2023 May 4.
5
Synthesis of Thiazole-Chalcone Hybrid Molecules: Antioxidant, Alpha(α)-Amylase Inhibition and Docking Studies.噻唑-查耳酮杂化分子的合成:抗氧化、α-淀粉酶抑制及对接研究。
Chem Biodivers. 2023 May;20(5):e202201134. doi: 10.1002/cbdv.202201134. Epub 2023 Apr 13.
6
Synthesis of thiazole-based-thiourea analogs: as anticancer, antiglycation and antioxidant agents, structure activity relationship analysis and docking study.噻唑基硫脲类似物的合成:作为抗癌、抗糖化和抗氧化剂,构效关系分析和对接研究。
J Biomol Struct Dyn. 2023;41(21):12077-12092. doi: 10.1080/07391102.2023.2171134. Epub 2023 Jan 25.
7
Eco-friendly sequential one-pot synthesis, molecular docking, and anticancer evaluation of arylidene-hydrazinyl-thiazole derivatives as CDK2 inhibitors.环保型顺序一锅法合成、芳甲叉-腙基-噻唑衍生物的分子对接及作为 CDK2 抑制剂的抗癌活性评价。
Bioorg Chem. 2021 Mar;108:104615. doi: 10.1016/j.bioorg.2020.104615. Epub 2021 Jan 5.
8
Synthesis, Molecular Docking Studies and In Silico ADMET Screening of New Heterocycles Linked Thiazole Conjugates as Potent Anti-Hepatic Cancer Agents.新型噻唑缀合物杂环的合成、分子对接研究及计算机 ADMET 筛选作为潜在的抗肝癌药物。
Molecules. 2021 Mar 18;26(6):1705. doi: 10.3390/molecules26061705.
9
Novel 2-indolinone thiazole hybrids as sunitinib analogues: Design, synthesis, and potent VEGFR-2 inhibition with potential anti-renal cancer activity.新型2-吲哚酮噻唑杂化物作为舒尼替尼类似物:设计、合成及对VEGFR-2的强效抑制作用与潜在抗肾癌活性
Eur J Med Chem. 2020 Dec 15;208:112752. doi: 10.1016/j.ejmech.2020.112752. Epub 2020 Aug 21.
10
Facile One-Pot Multicomponent Synthesis of Pyrazolo-Thiazole Substituted Pyridines with Potential Anti-Proliferative Activity: Synthesis, In Vitro and In Silico Studies.简便一锅法多组分合成具有潜在抗增殖活性的吡唑并噻唑取代吡啶:合成、体外和计算研究。
Molecules. 2021 May 22;26(11):3103. doi: 10.3390/molecules26113103.

引用本文的文献

1
Interactions of memantine and rivastigmine with graphene oxide nanocarrier and beta-amyloid protein using molecular docking and in-silico methods.使用分子对接和计算机模拟方法研究美金刚和卡巴拉汀与氧化石墨烯纳米载体及β-淀粉样蛋白的相互作用。
Heliyon. 2024 Sep 10;10(18):e37702. doi: 10.1016/j.heliyon.2024.e37702. eCollection 2024 Sep 30.
2
Synthesis, anti-diabetic profiling and molecular docking studies of 2-(2-arylidenehydrazinyl)thiazol-4(5)-ones.2-(2-芳基亚肼基)噻唑-4(5)-酮的合成、抗糖尿病特性研究及分子对接。
Future Med Chem. 2024;16(12):1255-1266. doi: 10.1080/17568919.2024.2342700. Epub 2024 May 10.
3
Synthesis of Fluorinated Hydrazinylthiazole Derivatives: A Virtual and Experimental Approach to Diabetes Management.
氟化肼基噻唑衍生物的合成:糖尿病管理的虚拟与实验方法
ACS Omega. 2023 Mar 17;8(12):11433-11446. doi: 10.1021/acsomega.3c00265. eCollection 2023 Mar 28.